TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Number of participants with principal anxiety disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve (AUC) 0-t
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility assessed by recruitment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility assessed by treatment adherence
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percent enrolled
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Kogan Attitudes Toward Old People Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cognitive Affective and Somatic Empathy Scales (CASES) for Children
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Ageism Attitude Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Blood count (Lab biochemistry)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Clinical chemistry (Lab biochemistry)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: all-cause maternal mortality
Endpoint domain: Mortality/survival
Primary endpoint: Social Resourcefulness
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in Cervical ROM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Functional disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Maximum Tolerated Dose (MTD) to the kidneys
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) to the bone marrow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: ICECAP-SCM
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: balance error scoring system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: star excursion balance test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time Up & Go Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor nerve function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Sensory nerve function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Intercultural Sensitivity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: recruitment screening eligibility
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: retention percentage
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: intervention acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Missing rate of Baveno criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in subjective wellbeing (global life satisfaction - present)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Dynamic platelet reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Tear Film Cytokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: incidence of hypotension events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of patients with a hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Relative dose intensity (RDI) of systemic treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AOFAS Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Recommended Phase 2 Dose (RP2D) or Optimal Biological Dose (OBD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time at Maximum Concentration (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impostor phenomenon score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Discrimination score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of the root mean square
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cytokine Release Syndrome
Endpoint domain: Adverse events/effects
Primary endpoint: Jerk in X,Y,Z
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Swaying in X,Y,Z
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of grade 3 or 4 treatment related adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Brain glucose uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in feelings of anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in umbilical artery Doppler indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes of Mini-mental State Examination (MMSE) score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes of Montreal cognitive assessment (MoCA) score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes of Hamilton Depression Scale (HAMD) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinical Surgical Site Infection (SSI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in Generic Quality of Life Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Wound Specific Quality of Life Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change of Diaphragma excursion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Opioid consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in postoperative pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of propofol infusion per hour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in MEP amplitude and latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Depth of anesthesia by bispectral index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in SSEP amplitude and latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean change in frequency of moderate to severe hot flash from baseline to Week 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in frequency of moderate to severe hot flash from baseline to Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in severity of moderate to severe hot flash from baseline to Week 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in severity of moderate to severe hot flash from baseline to Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of ventilatory anaerobic threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: System Usability Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: severity of dermatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Development of Late Allergic Reaction (LAR)
Endpoint domain: Adverse events/effects
Primary endpoint: Lead failure after HV shock
Endpoint domain: Adverse events/effects
Primary endpoint: Acute Kidney Injury at Day 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: First occurrence of confirmed symptomatic COVID-19 incidence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Safety and Tolerability of Treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Meaning in Life
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Opioid use at 3 months post-surgery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: NSAID use at 3 months post-surgery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Awareness of obstetric danger signs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Awareness of birth preparedness and complication readiness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: First-time malaria infection
Endpoint domain: Adverse events/effects
Primary endpoint: Implant Survival and Success
Endpoint domain: Mortality/survival
Primary endpoint: Symbol Digit Modality Test (SDMT) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Self-Administered Gerocognitive Examination (SAGE) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Stroop Word reading score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Increased behavioral capability
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Relative change in urinary protein content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in length of the children under 2 years of age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in weight of the children under 2 years of age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful bouts of Early Time-Restricted Eating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients agreeing to be enrolled in intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of participants completing the ADIE-FS programme
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of participants with CSQ-3 score ≥ 9
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of participants with TEQ score ≥ 50%
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Operator stress indicator 1
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Operator stress indicator 2
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Operator stress indicators 3
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Ulnar nerve conduction velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Lumbar reposition sense
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chronic non-specific neck pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the serum concentration-time curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kirkpatrick levels improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rate of successful spinal anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Most cranial dermatomal level of sensory anesthesia achieved before surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to recovery of normal sensation at T10 or lower
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Epigenetics signature related to stunting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of patients requiring reoperation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change of FMA-UE (Fugl Meyer Assessment for Upper Extremity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of IMM40H
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With t(11;14) Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percentage of Participants With BCL2 Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Perception of Tobacco Use Frequency Among Men
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perception of Tobacco Use Frequency Among Women
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perception of Alcohol Use Frequency Among Men
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perception of Alcohol Use Frequency Among Women
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perception of Alcohol-Related Blackouts Among Men
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perception of Alcohol-Related Blackouts Among Women
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adverse or severe adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Time to sustained clinical recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adhesive performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Grasp-Release Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of CR/CRi without MRD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success in Urination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Total Urination Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of Participants With at Least one Markedly Abnormal Value (MAV) for Laboratory Values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With at Least one MAV for Vital Signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With at Least one MAV for Electrocardiograms (ECGs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Discomfort during procedure
Endpoint domain: Adverse events/effects
Primary endpoint: 4-month Progression-Free Survival (PFS) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-month Progression-Free Survival (PFS) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fascicle dynamics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Muscle belly dynamics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Tendon dynamics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Reliable recovery - anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reliable recovery - depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reliable recovery - adjustment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Urinary incontinence severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Emotional Ratings of Personal Memories
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-confidence in clinical management of patients with low back pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ICU admission after surgery
Endpoint domain: Mortality/survival
Primary endpoint: Changes from Baseline in Sleep on the Pittsburgh Sleep Quality Index
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Changes from Baseline in Insomnia Severity on the Insomnia Severity Index
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Changes in serum vitamin D metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of Major Adverse Events (MAE) Within 30 Days Postoperative
Endpoint domain: Adverse events/effects
Primary endpoint: Success rate of thoracic and abdominal aortic aneurysm treatment after 12 months of surgery
Endpoint domain: Mortality/survival
Primary endpoint: cerebral desaturation (rSO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Agreement on Modified Rankin scale (mRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: General Comfort Scale (GCS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Dermatological Quality of Life index (DLQI)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Skin Moisture Measurement (DMM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Rate of perioperative mortality
Endpoint domain: Mortality/survival
Primary endpoint: Catherine Bergego Scale (CBS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in depression severity measured with the HDRS-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Sadness scale of PANAS-X
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Wexner Incontinence Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Wound Size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Safety of 4SCAR T cells
Endpoint domain: Adverse events/effects
Primary endpoint: Temporomandibular Dysfunction severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants with perioperative cerebral desaturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Stroke Impact Scale-16
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Stroke Impact Scale, perceived recovery
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: frequency of bowel sounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: wPCDAI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dose tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early discontinuations
Endpoint domain: Adverse events/effects
Primary endpoint: Clusters of activated microglia and macrophages
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Therapeutic effectiveness of gastric mucosal lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Nasa-Task Load Index (NASA-TLX)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ABILHAND change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Jebson Taylor Hand Function Assessment change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum tolerated dose (MTD) of TT-10
Endpoint domain: Adverse events/effects
Primary endpoint: Daily record of severity of problems
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Annualized Growth Velocity (GV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life of elderly patients
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Burnout among caregivers
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: California Verbal Learning Test (CVLT-II) Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from Baseline in Acne Severity Based on Investigator's Global Assessment Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Absolute Lesion Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of negative stereotypes towards older people
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Moderate to Vigorous Physical Activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Children's willingness to try novel foods
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients referred
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Low blood glucose index (LBGI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Difference in distance of the probe
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in angle of the probe
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: surgery-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Internal jugular vein area (cm2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of AF types in hemorrhagic infarction type 1 group
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes